{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:15:07Z","timestamp":1791332107504,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["614739-A_HERO"],"award-info":[{"award-number":["614739-A_HERO"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13071-015-1233-3","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T19:00:28Z","timestamp":1449601228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Fluorescence\/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays"],"prefix":"10.1186","volume":"8","author":[{"given":"Gordana","family":"Panic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayana","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ingram-Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"1233_CR1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJL Murray","year":"2012","unstructured":"Murray CJL, Vos T, Lozano R, Naghavi M, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197\u2013223.","journal-title":"Lancet"},{"key":"1233_CR2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368:1106\u201318.","journal-title":"Lancet"},{"key":"1233_CR3","unstructured":"WHO | Schistosomiasis [ http:\/\/www.who.int\/schistosomiasis\/strategy\/en\/ ]. Accessed date: 2015-03-02."},{"key":"1233_CR4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","volume":"373","author":"P Hotez","year":"2009","unstructured":"Hotez P, Fenwick A, Savioli L, Molyneux D. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009;373:1570\u20135.","journal-title":"Lancet"},{"key":"1233_CR5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4155\/fmc.15.11","volume":"7","author":"PM Cupit","year":"2015","unstructured":"Cupit PM, Cunningham C. What is the mechanism of action of praziquantel and how might resistance strike? Future Med Chem. 2015;7:701\u20135.","journal-title":"Future Med Chem"},{"key":"1233_CR6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4155\/fmc.15.9","volume":"7","author":"WE Secor","year":"2015","unstructured":"Secor WE, Montgomery SP. Something old, something new: is praziquantel enough for schistosomiasis control? Future Med Chem. 2015;7:681\u20134.","journal-title":"Future Med Chem"},{"key":"1233_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/S0074-02761989000500004","volume":"84","author":"MJ Doenhoff","year":"1989","unstructured":"Doenhoff MJ. The immune-dependence of chemotherapy in experimental schistosomiasis. Mem Inst Oswaldo Cruz. 1989;84:31\u20137.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1233_CR8","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1517\/17460441.2.S1.S53","volume":"2","author":"B Ramirez","year":"2007","unstructured":"Ramirez B, Bickle Q, Yousif F, Fakorede F, Mouries M-A, Nwaka S. Schistosomes: challenges in compound screening. Expert Opin Drug Discov. 2007;2:S53\u201361.","journal-title":"Expert Opin Drug Discov"},{"key":"1233_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/S0001-37652011000200024","volume":"83","author":"E Peak","year":"2011","unstructured":"Peak E, Hoffmann KF. Cross-disciplinary approaches for measuring parasitic helminth viability and phenotype. An Acad Bras Cienc. 2011;83:649\u201362.","journal-title":"An Acad Bras Cienc"},{"key":"1233_CR10","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","volume":"3","author":"M Abdulla","year":"2009","unstructured":"Abdulla M, Ruelas D, Wolff B. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis. 2009;3:e478.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR11","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1371\/journal.pntd.0000795","volume":"4","author":"NR Mansour","year":"1996","unstructured":"Mansour NR, Bickle QD. Comparison of microscopy and Alamar Blue reduction in a larval based assay for schistosome drug screening. PLoS Negl Trop Dis. 1996;4:e795.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0031182009991739","volume":"137","author":"J Keiser","year":"2010","unstructured":"Keiser J. In vitro and in vivo trematode models for chemotherapeutic studies. Parasitology. 2010;137:589\u2013603.","journal-title":"Parasitology"},{"key":"1233_CR13","doi-asserted-by":"crossref","first-page":"e885","DOI":"10.1371\/journal.pntd.0000885","volume":"4","author":"MJ Smout","year":"2010","unstructured":"Smout MJ, Kotze AC, Mccarthy JS, Loukas A. A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Negl Trop Dis. 2010;4:e885.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1128\/JCM.02382-10","volume":"49","author":"T Manneck","year":"2011","unstructured":"Manneck T, Braissant O, Haggenm\u00fcller Y, Keiser J. Isothermal microcalorimetry to study drugs against Schistosoma mansoni. J Clin Microbiol. 2011;49:1217\u201325.","journal-title":"J Clin Microbiol"},{"key":"1233_CR15","doi-asserted-by":"crossref","first-page":"e1762","DOI":"10.1371\/journal.pntd.0001762","volume":"6","author":"R Paveley","year":"2012","unstructured":"Paveley R, Mansour N. Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases. PLoS Negl Trop Dis. 2012;6:e1762.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR16","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1371\/journal.pntd.0000759","volume":"4","author":"E Peak","year":"2010","unstructured":"Peak E, Chalmers IW, Hoffmann KFK. Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability. PLoS Negl Trop Dis. 2010;4:e759.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.03809-14","volume":"59","author":"S Howe","year":"2015","unstructured":"Howe S, Z\u00f6phel D, Subbaraman H, Unger C, Held J, Engleitner T, et al. Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays. Antimicrob Agents Chemother. 2015;59:1193\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1233_CR18","doi-asserted-by":"crossref","first-page":"e0003484","DOI":"10.1371\/journal.pntd.0003484","volume":"9","author":"C Lalli","year":"2015","unstructured":"Lalli C, Guidi A, Gennari N, Altamura S, Bresciani A, Ruberti G. Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni. PLoS Negl Trop Dis. 2015;9:e0003484.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","volume":"68","author":"B R\u00e4z","year":"1997","unstructured":"R\u00e4z B, Iten M, Grether-B\u00fchler Y, Kaminsky R, Brun R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop. 1997;68:139\u201347.","journal-title":"Acta Trop"},{"issue":"Suppl(May)","key":"1233_CR20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0074-02762006000900045","volume":"101","author":"AK Sarvel","year":"2006","unstructured":"Sarvel AK, Kusel JR, Ara\u00fajo N, Coelho P, Katz N. Comparison between morphological and staining characteristics of live and dead eggs of Schistosoma mansoni. Mem Inst Oswaldo Cruz. 2006;101(Suppl(May)):289\u201392.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1233_CR21","doi-asserted-by":"crossref","unstructured":"Deelder AM. Schistosoma mansoni : A Diamidinophenylindole probe for in vitro death of schistosomula. Exp Parasitol. 1984;57:125\u201331.","DOI":"10.1016\/0014-4894(84)90071-7"},{"key":"1233_CR22","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1128\/AAC.06177-11","volume":"56","author":"K Ingram","year":"2012","unstructured":"Ingram K, Ellis W, Keiser J. Antischistosomal activities of mefloquine-related arylmethanols. Antimicrob Agents Chemother. 2012;56:3207\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"1233_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1756-3305-5-165","volume":"5","author":"M Marxer","year":"2012","unstructured":"Marxer M, Ingram K, Keiser J. Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula. Parasit Vectors. 2012;5:165.","journal-title":"Parasit Vectors"},{"key":"1233_CR24","doi-asserted-by":"crossref","first-page":"e0003962","DOI":"10.1371\/journal.pntd.0003962","volume":"9","author":"G Panic","year":"2015","unstructured":"Panic G, Vargas M, Scandale I, Keiser J. Activity Profile of an FDA-Approved compound library against Schistosoma mansoni. PLoS Negl Trop Dis. 2015;9:e0003962.","journal-title":"PLoS Negl Trop Dis"},{"key":"1233_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"J Zhang","year":"1999","unstructured":"Zhang J, Chung T, Oldenburg K. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4:67\u201373.","journal-title":"J Biomol Screen"},{"key":"1233_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cbpa.2007.05.031","volume":"11","author":"CR Caffrey","year":"2007","unstructured":"Caffrey CR. Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol. 2007;11:433\u20139.","journal-title":"Curr Opin Chem Biol"},{"key":"1233_CR27","unstructured":"Haggenm\u00fcller Y: Development and validation of an in vitro drug screening assay based on S. mansoni schistosomula. Master's Thesis. University of Basel, Swiss Tropical and Public Health Institute; 2009."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-1233-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T21:11:06Z","timestamp":1498252266000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.parasitesandvectors.com\/content\/8\/1\/624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1186\/s13071-015-1233-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"624"}}